Colleran David
- SEC CIK
- 0001646558
No open-market purchases or sales filed in the past year.
Current role at each company
- ANIK Anika Therapeutics, Inc.EVP, General Counsel, Corp Secas of Mar 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Colleran David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2022 (view filing) | May 11 | 1 day | Colleran DavidEVP, General Counsel, Corp Sec | PPurchase | +1.50K | $21.37 | +$32.1K | +17.9%9.87K after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Colleran DavidEVP, General Counsel, Corp Sec | PPurchase | +1.50K | $26.65 | +$40.0K | +21.8%8.37K after |